Literature DB >> 35358413

2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium: Meeting highlights.

Anil Kapoor1, Tamim Niazi2, Krista Noonan3, Ricardo A Rendon4, Nimira Alimohamed5, Wassim Kassouf6, Alejandro Berlin7, William Chu8, Christian Kollmannsberger9, Alan I So10.   

Abstract

Entities:  

Year:  2022        PMID: 35358413      PMCID: PMC9054327          DOI: 10.5489/cuaj.7875

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   2.052


× No keyword cloud information.
  11 in total

1.  Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Noel Clarke; Pawel Wiechno; Boris Alekseev; Nuria Sala; Robert Jones; Ivo Kocak; Vincenzo Emanuele Chiuri; Jacek Jassem; Aude Fléchon; Charles Redfern; Carsten Goessl; Joseph Burgents; Robert Kozarski; Darren Hodgson; Maria Learoyd; Fred Saad
Journal:  Lancet Oncol       Date:  2018-06-04       Impact factor: 41.316

2.  Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.

Authors:  Kim N Chi; Simon Chowdhury; Anders Bjartell; Byung Ha Chung; Andrea J Pereira de Santana Gomes; Robert Given; Alvaro Juárez; Axel S Merseburger; Mustafa Özgüroğlu; Hirotsugu Uemura; Dingwei Ye; Sabine Brookman-May; Suneel D Mundle; Sharon A McCarthy; Julie S Larsen; Weili Sun; Katherine B Bevans; Ke Zhang; Nibedita Bandyopadhyay; Neeraj Agarwal
Journal:  J Clin Oncol       Date:  2021-04-29       Impact factor: 44.544

Review 3.  Renal Cell Carcinoma: Alternative Nephron-Sparing Treatment Options for Small Renal Masses, a Systematic Review.

Authors:  Fieke M Prins; Linda G W Kerkmeijer; Anne A Pronk; Evert-Jan P A Vonken; Richard P Meijer; Axel Bex; Maurits M Barendrecht
Journal:  J Endourol       Date:  2017-08-22       Impact factor: 2.942

4.  Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study.

Authors:  Patrick Cheung; Samir Patel; Scott A North; Arjun Sahgal; William Chu; Hany Soliman; Belal Ahmad; Eric Winquist; Tamim Niazi; Francois Patenaude; Gerald Lim; Daniel Yick Chin Heng; Arbind Dubey; Piotr Czaykowski; Rebecca K S Wong; Anand Swaminath; Scott C Morgan; Rupi Mangat; Sareh Keshavarzi; Georg A Bjarnason
Journal:  Eur Urol       Date:  2021-08-13       Impact factor: 20.096

5.  Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.

Authors:  Vishnukamal Golla; Yong Shan; Elias J Farran; Courtney A Stewart; Kevin Vu; Alexander Yu; Ali Raza Khaki; Divya Ahuja Parikh; Todd A Swanson; Kirk A Keegan; Ashish M Kamat; Douglas S Tyler; Stephen J Freedland; Stephen B Williams
Journal:  Urol Oncol       Date:  2022-02-12       Impact factor: 3.498

6.  Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.

Authors:  Matthew R Smith; Maha Hussain; Fred Saad; Karim Fizazi; Cora N Sternberg; E David Crawford; Evgeny Kopyltsov; Chandler H Park; Boris Alekseev; Álvaro Montesa-Pino; Dingwei Ye; Francis Parnis; Felipe Cruz; Teuvo L J Tammela; Hiroyoshi Suzuki; Tapio Utriainen; Cheng Fu; Motohide Uemura; María J Méndez-Vidal; Benjamin L Maughan; Heikki Joensuu; Silke Thiele; Rui Li; Iris Kuss; Bertrand Tombal
Journal:  N Engl J Med       Date:  2022-02-17       Impact factor: 91.245

7.  Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.

Authors:  David A Kunkle; Robert G Uzzo
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

8.  Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.

Authors:  Thomas Powles; Se Hoon Park; Eric Voog; Claudia Caserta; Begoña P Valderrama; Howard Gurney; Haralabos Kalofonos; Siniša Radulović; Wim Demey; Anders Ullén; Yohann Loriot; Srikala S Sridhar; Norihiko Tsuchiya; Evgeny Kopyltsov; Cora N Sternberg; Joaquim Bellmunt; Jeanny B Aragon-Ching; Daniel P Petrylak; Robert Laliberte; Jing Wang; Bo Huang; Craig Davis; Camilla Fowst; Nuno Costa; John A Blake-Haskins; Alessandra di Pietro; Petros Grivas
Journal:  N Engl J Med       Date:  2020-09-18       Impact factor: 91.245

9.  TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.

Authors:  Scott T Tagawa; Arjun V Balar; Daniel P Petrylak; Arash Rezazadeh Kalebasty; Yohann Loriot; Aude Fléchon; Rohit K Jain; Neeraj Agarwal; Manojkumar Bupathi; Philippe Barthelemy; Philippe Beuzeboc; Phillip Palmbos; Christos E Kyriakopoulos; Damien Pouessel; Cora N Sternberg; Quan Hong; Trishna Goswami; Loretta M Itri; Petros Grivas
Journal:  J Clin Oncol       Date:  2021-04-30       Impact factor: 50.717

Review 10.  Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

Authors:  Valeria Panebianco; Yoshifumi Narumi; Ersan Altun; Bernard H Bochner; Jason A Efstathiou; Shaista Hafeez; Robert Huddart; Steve Kennish; Seth Lerner; Rodolfo Montironi; Valdair F Muglia; Georg Salomon; Stephen Thomas; Hebert Alberto Vargas; J Alfred Witjes; Mitsuru Takeuchi; Jelle Barentsz; James W F Catto
Journal:  Eur Urol       Date:  2018-05-10       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.